News
In a retrospective study, overlapping biologic therapy for ulcerative colitis or Crohn disease did not significantly increase risk of infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback